After Plunging -17.61% in 4 Weeks, Here's Why the Trend Might Reverse for Cellebrite DI Ltd. (CLBT)

Group 1 - Cellebrite DI Ltd. (CLBT) has experienced a significant decline of 17.6% over the past four weeks, but it is now in oversold territory, indicating a potential trend reversal [1] - The Relative Strength Index (RSI) for CLBT is currently at 28.57, suggesting that the heavy selling pressure may be exhausting itself [5] - There is strong consensus among Wall Street analysts that CLBT will report better earnings than previously predicted, with a 10.2% increase in the consensus EPS estimate over the last 30 days [6] Group 2 - CLBT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [7]